[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AR046645A1 - Benzofuranos y benzotiofenos,procedimiento de preparacion y usos - Google Patents

Benzofuranos y benzotiofenos,procedimiento de preparacion y usos

Info

Publication number
AR046645A1
AR046645A1 ARP040104274A ARP040104274A AR046645A1 AR 046645 A1 AR046645 A1 AR 046645A1 AR P040104274 A ARP040104274 A AR P040104274A AR P040104274 A ARP040104274 A AR P040104274A AR 046645 A1 AR046645 A1 AR 046645A1
Authority
AR
Argentina
Prior art keywords
alk
nrr
het
oalk
hal
Prior art date
Application number
ARP040104274A
Other languages
English (en)
Inventor
Gerard Moinet
Caroline Leriche
Micheline Kergoat
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of AR046645A1 publication Critical patent/AR046645A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente se refiere a compuestos de la fórmula general (1), en donde: X = O ó S; R1 se selecciona de: -Alk-COOH; -Alk-C(=O)-(O)m-Ar; -Alk-C(=O)-(O)m-Het; -Alk-C(=O)-(O)m-Alk; -Alk-C(=O)-(O)m-cicloalquilo; -Alk-C(=O)NRR'; -Alk-(O)m-Ar; -Alk-O-Alk; -Alk-O-Alk-Ar; -Alk-O-Het; R2 se selecciona del -Alk, -Ar y -cicloalquilo; R3, R4, R5, y R6, que pueden ser idénticos o diferentes, se seleccionan, de manera independiente, de H, -Hal, -OH, -Alk, -OAlk, -CN, -CF3, -NRR' y -NO2; en donde, en las definiciones de R1-R6: cada uno de Alk, que pueden ser idénticos o diferentes, está opcional e independientemente sustituido con uno o varios grupos seleccionados de -Hal, -OAlk, -Ar, -OAlkAr, -OH, -CN, -OAr, -CF3, -COOH, -NRR', -C(=O)-(O)mAlk, -Het y -NO2; cada uno de Ar, que pueden ser idénticos o diferentes, está opcional e independientemente sustituido con uno o varios grupos seleccionados de -Hal, -OAlk, -Alk, -Ar, OAlkAr, -OH, -CN, -OAr, -CF3, -AlkAr, -COOH, -C(=O)-(O)mAlk, -Alk-C(=O)- (O)m-Alk, -NRR', -Het y -NO2, -S(O)nAr y -S(O)nAlk; R y R' se seleccionan, de manera independiente, de H y Alk; m = 0 ó 1; y también sus estereoisómeros, sus racematos y las sales farmacéuticamente aceptables, a excepción de los compuestos para los cuales: R1 = -CH2-C(=O)Me; R2 = -Me; X = O; R3, R5 = H y cada R4, R6 = H u OMe. Estos compuestos se pueden usar en el tratamiento de patologías asociadas al síndrome de resistencia a la insulina.
ARP040104274A 2003-11-20 2004-11-19 Benzofuranos y benzotiofenos,procedimiento de preparacion y usos AR046645A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0313615A FR2862646B1 (fr) 2003-11-20 2003-11-20 Nouveaux composes antidiabetiques contenant des derives benzofuranes, benzothiophenes

Publications (1)

Publication Number Publication Date
AR046645A1 true AR046645A1 (es) 2005-12-14

Family

ID=34531152

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040104274A AR046645A1 (es) 2003-11-20 2004-11-19 Benzofuranos y benzotiofenos,procedimiento de preparacion y usos

Country Status (16)

Country Link
US (1) US7371774B2 (es)
EP (1) EP1685122B1 (es)
JP (1) JP4819692B2 (es)
KR (1) KR20060101492A (es)
CN (1) CN1882562A (es)
AR (1) AR046645A1 (es)
AT (1) ATE400566T1 (es)
AU (1) AU2004295036B9 (es)
BR (1) BRPI0416790A (es)
CA (1) CA2546651C (es)
DE (1) DE602004014966D1 (es)
ES (1) ES2308270T3 (es)
FR (1) FR2862646B1 (es)
MX (1) MXPA06005591A (es)
WO (1) WO2005054226A1 (es)
ZA (1) ZA200605022B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2862645B1 (fr) * 2003-11-20 2007-06-22 Merck Sante Sas Composes antidiabetiques contenant des derives benzofuranes, benzothiophenes
GB0506133D0 (en) * 2005-03-24 2005-05-04 Sterix Ltd Compound
CN101830872A (zh) * 2010-04-14 2010-09-15 南方医科大学 一种3-羟基苯并呋喃类衍生物的合成方法
CA3008020C (en) 2015-12-09 2024-02-20 The Board Of Trustees Of The University Of Illinois Benzothiophene-based selective estrogen receptor downregulators
WO2018081168A2 (en) * 2016-10-24 2018-05-03 The Board Of Trustees Of The University Of Illinois Benzothiophene-based selective mixed estrogen receptor downregulators
EP3565558B1 (en) 2017-01-06 2023-12-06 G1 Therapeutics, Inc. Combination therapy with a serd compound and a cdk4/6 inhibitor for the treatment of cancer
WO2018148576A1 (en) 2017-02-10 2018-08-16 G1 Therapeutics, Inc. Benzothiophene estrogen receptor modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1084290A (es) * 1963-12-02 1900-01-01
SE351639B (es) * 1964-11-11 1972-12-04 Haessle Ab
JPH10175970A (ja) * 1996-12-19 1998-06-30 Mitsui Chem Inc ベンゾチオフェン誘導体およびそれを有効成分として含有する医薬品
AU3791799A (en) * 1998-05-12 1999-11-29 American Home Products Corporation Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
AU2001285067A1 (en) * 2000-09-19 2002-04-02 Warner Lambert Company Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
JP2006526608A (ja) * 2003-06-05 2006-11-24 ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー Ｐｉ３ｋ活性を有する治療薬としてのテトラゾールベンゾフランカルボキシアミド
FR2862645B1 (fr) * 2003-11-20 2007-06-22 Merck Sante Sas Composes antidiabetiques contenant des derives benzofuranes, benzothiophenes

Also Published As

Publication number Publication date
FR2862646A1 (fr) 2005-05-27
ZA200605022B (en) 2007-10-31
ES2308270T3 (es) 2008-12-01
WO2005054226A1 (en) 2005-06-16
CA2546651C (en) 2012-12-18
EP1685122A1 (en) 2006-08-02
CA2546651A1 (en) 2005-06-16
AU2004295036B2 (en) 2010-12-23
JP2007511556A (ja) 2007-05-10
ATE400566T1 (de) 2008-07-15
DE602004014966D1 (de) 2008-08-21
AU2004295036A1 (en) 2005-06-16
CN1882562A (zh) 2006-12-20
JP4819692B2 (ja) 2011-11-24
US20070066680A1 (en) 2007-03-22
MXPA06005591A (es) 2006-08-11
US7371774B2 (en) 2008-05-13
EP1685122B1 (en) 2008-07-09
BRPI0416790A (pt) 2007-03-06
KR20060101492A (ko) 2006-09-25
AU2004295036B9 (en) 2011-02-03
FR2862646B1 (fr) 2006-02-24

Similar Documents

Publication Publication Date Title
ECSP10010178A (es) Derivados bis-(sulfonilamino) en terapia 066
PE20212302A1 (es) Inhibidores de apol1 y sus metodos de uso
AR063211A1 (es) Derivados de 3-(piridin-3-il)acrilamida y 3-(piridin-3-il)propionamida, un metodo para su preparacion, una composicion farmaceutica que los comprende y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades asociadas con el receptor vaniloide.
AR038047A1 (es) Agentes terapeuticos
ECSP066671A (es) Nuevos derivados de quinolina
UY27427A1 (es) Nuevas dihidro-pteridinonas, procedimientos para su preparación y su utilización como medicamentos
NO20075623L (no) Benzodioksan- og benzodioksolanderivater og deres anvendelse
UY28514A1 (es) Nuevos compuestos
AR067779A1 (es) Profarmacos dipeptoides y su uso
ECSP045347A (es) "derivados de acil-4-carboxifenilurea, procedimientos para su preparacion y su uso"
UY31468A1 (es) Derivados bis-(sulfonilamino) en terapia 065
PE20040909A1 (es) Derivados fluoroglicosidos aromaticos con afinidad por el receptor sglt2
UY31546A1 (es) Derivados bis-(sulfonilamino) en terapia 205
ECSP045483A (es) Derivados de heteroarilamida benzocondensada de tienopiridinas útiles como agentes terapéuticos, composiciones farmacéuticas que incluyen a los mismos, y métodos para su uso
ECSP066730A (es) Compuestos y procedimientos para uso
PA8621901A1 (es) Derivados de sulfonamida para el tratamiento de enfermedades
PE20140968A1 (es) Derivados de benzamida sustituida
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
UY30377A1 (es) Inhibidores triciclicos fusionados de sulfonamida de gama-secretasa
AR067808A1 (es) Pirrolidina -aril-eteres como antagonistas de receptor de nk3
SV2004001555A (es) Difenilazetidinonas cationicamente sustituidas, procesos para su preparacion, medicamentos que contienen estos compuestos y sus usos
AR046645A1 (es) Benzofuranos y benzotiofenos,procedimiento de preparacion y usos
UY27685A1 (es) Indolil-urea derivados de tienopiridinas útiles como agentes antiangiogénicos, y procedimientos para su uso
UY27803A1 (es) Derivados de benzoxazina y usos de los mismos.
AR043620A1 (es) Derivados 7-imino de camptotecinas que tienen actividad antitumoral

Legal Events

Date Code Title Description
FB Suspension of granting procedure